Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-27 @ 11:20 PM
Study NCT ID:
NCT05565794
Status:
TERMINATED
Last Update Posted:
2025-04-13
First Post:
2022-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-27
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-28
First Submit QC Date:
None
Study First Post Date:
2022-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-10
Last Update Post Date:
2025-04-13
Last Update Post Date Type:
ACTUAL